RESMED INC — Director's Dealing 2015

Aug 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-08-17

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-17	ResMed Common Stock	M	5975	$15.52	Acquired	128414.946	Direct
2015-08-17	ResMed Common Stock	S	5975	$55.54	Disposed	122439.946	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-17	ResMed Common Stock Options	$15.52	M	5975	Disposed	2015-11-20	ResMed Commmon Stock (5975)	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 annually.